AnatomyOrganismsDiseasesChemicals and DrugsAnalytical, Diagnostic and Therapeutic Techniques and EquipmentPhenomena and ProcessesAnthropology, Education, Sociology and Social PhenomenaInformation ScienceHealth CareGeographicals
Myocardial InfarctionExercise TestExercise ToleranceExerciseElectrocardiographyExercise TherapyInfarctionCoronary AngiographyTime FactorsAngioplasty, Balloon, CoronaryPhysical ExertionOxygen ConsumptionCerebral InfarctionTreatment OutcomeMyocardial ReperfusionAngina PectorisRisk FactorsProspective StudiesThrombolytic TherapyHeart RateCoronary DiseaseAnterior Wall Myocardial InfarctionStreptokinaseCreatine KinaseCoronary CirculationFollow-Up StudiesPredictive Value of TestsVentricular RemodelingVentricular Function, LeftPrognosisPhysical EnduranceStroke VolumeAnaerobic ThresholdMyocardial IschemiaAngina, UnstableEchocardiographyPlatelet Aggregation InhibitorsMyocardiumHeart FailureRisk AssessmentCoronary Artery DiseaseHemodynamicsPhysical FitnessHeartCoronary Care UnitsCoronary ThrombosisVentricular Dysfunction, LeftCoronary VesselsChest PainStentsAsthma, Exercise-InducedFibrinolytic AgentsPercutaneous Coronary InterventionRetrospective StudiesMyocardial RevascularizationRecurrenceShock, CardiogenicDouble-Blind MethodBiological MarkersBicyclingAdrenergic beta-AntagonistsBlood PressureAcute DiseaseHospital MortalityPulmonary Gas ExchangeProportional Hazards ModelsCardiac CatheterizationMuscle, SkeletalAcute Coronary SyndromeCohort StudiesCoronary Artery BypassHeart VentriclesInferior Wall Myocardial InfarctionCase-Control StudiesMultivariate AnalysisArrhythmias, CardiacAspirinRestSurvival AnalysisHemorrhageLactic AcidRegistriesSeverity of Illness IndexStrokeAnalysis of VarianceIncidenceChi-Square DistributionDeath, Sudden, CardiacElectrocardiography, AmbulatoryErgometryTomography, Emission-Computed, Single-PhotonAge FactorsHeart Function TestsCardiovascular AgentsThallium RadioisotopesImmunoglobulin Fab FragmentsCardiovascular DiseasesRandomized Controlled Trials as TopicSex FactorsSurvival Rate
AcuteSTEMIUnstable anginaElevationThrombolysisNecrosisMillion myocardial infarctionsRevascularizationIschemiaIschemicPatientsStratificationOutcomesDiagnosisIschaemiaTroponinCoronary angiographyInhibitorsStentsInvestigatorsTissueTrialsDischargeRiskSymptomSystolicResultsAnnuallyAnginaTachycardiaChest painLogistic regressionClinicalArteryNoninvasiveTreadmillProximal
Acute25
  • The C-statistics of the clinical score for long-term (0.75) and 30-day (0.88) MACE were higher than with the TIMI(Thrombolysis In Myocardial Infarction) risk (0.68, 0.77) or GRACE(Global Registry of Acute Coronary Events) (0.50, 0.47) scores. (thoracickey.com)
  • The TIMI (Thrombolysis In Myocardial Infarction) risk score and the GRACE (Global Registry of Acute Coronary Events) score for 6-month death or myocardial infarction were calculated. (thoracickey.com)
  • Recognizing that cardiac troponin measurements may be elevated in disease states not primarily related to myocardial ischemia, a fourth universal definition of acute MI was developed by the American College of Cardiology (ACC), European Society of Cardiology (ESC), American Hospital Association (AHA), and World Health Federation (WHF) in 2018. (medscape.com)
  • Patients with persistent ST segment elevation or acute Q wave myocardial infarction, and those with alternative diagnoses, exit from this guideline and should be managed appropriately. (bmj.com)
  • Copeptin has been proposed for a rapid and accurate rule out of acute myocardial infarction, but some doubts exist about its use out of the first hours from admission. (hindawi.com)
  • found that the diagnostic performance of sensitivity cardiac Tn assays is excellent within the context of the myocardial infarction, and these assays can substantially improve the early diagnosis of acute myocardial infarction, particularly in patients with a recent onset of chest pain [ 14 ]. (hindawi.com)
  • Overcoming thrombolytic resistance: rationale and initial clinical experience combining thrombolytic therapy and glycoprotein IIb/IIIa receptor inhibition for acute myocardial infarction. (baiminstitute.org)
  • Unlike the other type of acute coronary syndrome, unstable angina, a myocardial infarction occurs when there is cell death, which can be estimated by measuring by a blood test for biomarkers (the cardiac protein troponin). (wikipedia.org)
  • Chest pain is one of the most common symptoms of acute myocardial infarction and is often described as a sensation of tightness, pressure, or squeezing. (wikipedia.org)
  • Over the past 18 years, multiple studies have examined the utility of ST elevation in aVR for predicting severe coronary artery disease (proximal LAD/LMCA/3VD) and mortality in patients with acute coronary syndromes and those undergoing exercise stress testing. (litfl.com)
  • Acute myocardial infarction is myocardial necrosis resulting from acute obstruction of a coronary artery. (msdmanuals.com)
  • Acute MI includes both non-ST-segment elevation myocardial infarction (NSTEMI) and ST-segment elevation myocardial infarction (STEMI). (msdmanuals.com)
  • Pathophysiology references Acute myocardial infarction is myocardial necrosis resulting from acute obstruction of a coronary artery. (msdmanuals.com)
  • Unstable angina belongs to the spectrum of clinical presentations referred to collectively as acute coronary syndromes (ACSs), which range from ST-segment elevation myocardial infarction (STEMI) to non-STEMI (NSTEMI). (medscape.com)
  • The 2018 ACEP clinical policy paper on suspected non ST elevation ACS* asks: "In adult patients with suspected NSTEMI ACS in whom acute MI has been excluded, does further diagnostic testing for ACS prior to discharge reduce 30-day MACE? (tomwademd.net)
  • Level B recommendation: "Do not routinely use further diagnostic testing prior to discharge in low risk patients in whom acute MI has been ruled out to reduce 30-day MACE. (tomwademd.net)
  • Background The purpose of this study was to use the findings of a fibrinolysis and subsequent transluminal trial (FAST-3) to evaluate the association between the target time for obtaining a thrombolysis in myocardial infarction (TIMI)-3 flow after arrival at the emergency room with acute myocardial infarction (AMI) and the degree of myocardial salvage. (go.jp)
  • Davies MJThomas AC Plaque fissuring: the cause of acute myocardial infarction, sudden ischemic death, and crescendo angina. (jamanetwork.com)
  • 1999 Update: ACC/AHA guidelines for the management of patients with acute myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). (jamanetwork.com)
  • Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. (jamanetwork.com)
  • Théroux PWaters DQiu SMcCans JDe Guise PJuneau M Aspirin versus heparin to prevent myocardial infarction during the acute phase of unstable angina. (jamanetwork.com)
  • If treatment is initiated within 3 hours of onset of symptoms for acute myocardial infarction, the drug preserves myocardial tissue and left ventricular function and increases coronary artery patency. (lookformedical.com)
  • The aim of this study is to investigate the clinical effectiveness and patient satisfaction of a smart technology intervention in patients admitted with a ST elevation myocardial infarction (STEMI) or non-ST acute coronary syndrome (NST-ACS). (researchprotocols.org)
  • Unstable coronary artery plaque is the most common underlying cause of acute coronary syndromes (ACS) and can manifest as unstable angina, non-ST segment elevation infarction (NSTE-ACS), and ST elevation myocardial infarction (STEMI), but can also manifest as sudden cardiac arrest due to ischaemia induced tachyarrhythmias. (romanianjournalcardiology.ro)
  • For patients with suspected acute coronary syndromes (ACS), CT angiography (CTA) compared to standard treatment can reduce the time in the emergency department (ED), according to results of the ROMICAT-II (Rule Out Myocardial Infarction/Ischemia Using Computer-Assisted Tomography) trial, published in the New England Journal of Medicine. (jwatch.org)
STEMI4
Unstable angina10
  • For example, patients with elevated troponin levels but negative CK-MB values who were formerly diagnosed with unstable angina or minor myocardial injury are now reclassified as non-ST-segment elevation MI (NSTEMI), even in the absence of diagnostic electrocardiographic (ECG) changes. (medscape.com)
  • A total of 824 patients with a diagnosis of myocardial infarction or unstable angina were analyzed. (hindawi.com)
  • A total of 853 patients were initially admitted during the period studied with a discharge diagnosis of unstable angina or myocardial infarction. (hindawi.com)
  • Patients with unstable angina or non-Q wave myocardial infarction should have their cardiac prognosis assessed by estimation of their risk of death or further cardiac events. (bmj.com)
  • Those patients with unstable angina or non-Q wave myocardial infarction whose condition has stabilised, but who are at high risk of death or further cardiac events , should be referred for coronary angiography. (bmj.com)
  • Glycoprotein IIb/IIIa inhibitors in unstable angina and non-ST segment elevation myocardial infarction. (baiminstitute.org)
  • Unstable angina is considered to be an ACS in which there is no detectable release of the enzymes and biomarkers of myocardial necrosis. (medscape.com)
  • The patient's history and diagnostic testing are generally more sensitive and specific for unstable angina than the physical examination, which may be unremarkable. (medscape.com)
  • Falk E Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death: autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion. (jamanetwork.com)
  • The TIMI IIIB Investigators, Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction: results of the TIMI IIIB trial. (jamanetwork.com)
Elevation4
Thrombolysis2
Necrosis1
  • Cardiac troponins are components of the contractile apparatus of cardiomyocytes and are released during myocardial necrosis in patients with ACS [ 7 ]. (hindawi.com)
Million myocardial infarctions1
  • Worldwide, about 15.9 million myocardial infarctions occurred in 2015. (wikipedia.org)
Revascularization3
Ischemia1
Ischemic2
  • When the first sham-controlled ORBITA trial showed that percutaneous coronary intervention (PCI) relieved ischemic left ventricular dysfunction but that nearly all of the symptom and exercise improvement stemmed from placebo effect, cardiologists struggled to believe it. (medscape.com)
  • The anterior wall is still ischemic, despite report of TIMI 3 flow in the epicardial portion of the LAD. (blogspot.com)
Patients24
  • 24 of them were discharged after a negative exercise test result, and the 70 remaining patients were hospitalized. (thoracickey.com)
  • In patients whose symptoms and condition have become stable after initial treatment, this assessment should include stress testing. (bmj.com)
  • A meta-analysis of nearly 5000 patients found that statins administered before invasive procedures significantly reduced the risk for postprocedural myocardial infarction. (medscape.com)
  • 191 patients) Monotherapy Assessment of Ranolazine In Stable Angina trial was a dose-response study that showed increasing doses of razonaline increased exercise duration by 94, 103 and 116 seconds. (escardio.org)
  • Patients treated with ranolazine had significantly better exercise duration - an ncrease by 115 seconds from baseline versus 91 seconds in placebo group - time to onset of angina, and fewer angina attacks. (escardio.org)
  • Sixty years later, cardiac stress testing has been pretty much the standard for screening low risk chest pain patients for coronary disease after a visit to the ED. It makes intuitive sense. (tomwademd.net)
  • In this Journal Jam podcast we do a deep dive into the hugely complex literature of cardiac stress testing and see whether or not stress testing portends any benefit for patients who we assess in the ED for chest pain. (tomwademd.net)
  • The problem is - if stress testing doesn't benefit our patients and isn't a good screening test for preventing MIs, then what do we do with our low risk chest pain patients we see in the ED? (tomwademd.net)
  • The patients who are sent for stress tests after a negative ED workup are extremely low risk to begin with. (tomwademd.net)
  • They are poor at identifying coronary artery disease and stress test studies in low risk chest pain patients suffer from inclusion bias. (tomwademd.net)
  • Patients with negative ED workups but positive stress tests usually go on to have angiograms and some get stents or CABG. (tomwademd.net)
  • Based on in vivo thrombogenicity testing, the device should not be used in patients who cannot be anticoagulated as there may be some thrombus formation in the absence of anticoagulation. (cardiovascular.abbott)
  • Antiplatelet Trialists' Collaboration, Collaborative overview of randomised trials of antiplatelet therapy I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. (jamanetwork.com)
  • Four patients of the placebo group had a dissection requiring PCI and four were withdrawn during follow-up, two because of a chest pain admission, one for a COPD exacerbation with right sided heart failure, and one for bilateral leg pain, all four of whom would likely have had worse exercise performance than average. (medscape.com)
  • 9 The 2016 AHA/ACC guidelines, 2017 ESC guidelines and 2019 ESVM guidelines recommend a supervised and structured exercise programme together with medical therapies aimed at reducing limb symptoms by suppressing platelet aggregation and promoting vasodilation to manage the limb symptoms in patients with PAD. (thrombosisadviser.com)
  • Chez les patients hypertendus, le taux de mortalité était plus élevé uniquement chez les patients admis pour un infarctus du myocarde avec sus-décalage du segment ST. Après ajustement des résultats en fonction des variables de référence, l'hypertension s'est révélé être un facteur prédictif indépendant de l'insuffisance cardiaque (OR = 1,31) et de l'accident vasculaire cérébral (OR = 2,47). (who.int)
  • BODE Index for COPD Survival Prediction Estimates prognosis in patients with COPD based on body mass index, airflow obstruction, dyspnea, and exercise. (bmj.com)
  • Smart technology could potentially improve care in postmyocardial infarction patients. (researchprotocols.org)
  • A recent large scale randomized trial in 452 patients, INFUSE-AMI ( Intracoronary Abciximab and Aspiration Thrombectomy in Patients with Large Anterior Myocardial Infarction ) did not demonstrate an effect of manual thrombus aspiration on infarct size when used in conjunction with bivalirudin (and intracoronary abciximab)6,7. (romanianjournalcardiology.ro)
  • Earlier trials such as TIMI 11B and ESSENCE demonstrated superiority of enoxaparin versus UFH in patients with ACSs. (acc.org)
  • The potential of dynamic (99m)Tc-sestamibi cadmium zinc telluride-single-photon emission computed tomography camera assessing myocardial flow reserve in patients with heart failure with preserved ejection fraction. (nagoya-u.ac.jp)
  • A novel single-photon emission computed tomography (SPECT) camera with cadmium zinc telluride (CZT) detectors allows for the quantification of absolute myocardial blood flow and myocardial flow reserve (MFR) in patients with coronary artery disease. (nagoya-u.ac.jp)
  • Bisphosphonate Treatment of calcium renal lithiasis with bisphosphonate is novel but, despite the sparseness of studies counter strike fly hack buy cheap its indication, fasting and hour tests have reported decreases in calciuria among patients with calcium renal lithiasis and loss of bone mineral density, following this treatment. (peixesradamar.es)
  • Rökstopp är ett högeffektivt sätt att förbättra framtidsprognosen för patienter med kranskärlssjukdom (en metaanlys av 12000 patienter i 20 observationsstudier räknade fram en 36 % minskning i mortalitet ), [2] Critchley JA, Capewell S. Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review. (kardiologi.se)
Stratification1
  • They argue that limiting complex, expensive, and time-consuming testing can reduce patient cost, ED and hospital length of stay, and patient anxiety caused by unnecessary stress testing and potentially false-positive results, once adequate risk stratification and cardiac rule-out have occurred. (tomwademd.net)
Outcomes2
  • EASD 2013 featured rich discussion and commentary on long-term outcomes trials, especially on SAVOR-TIMI 53 and EXAMINE, the CVOTs for BMS/AZ's Onglyza (saxagliptin) and Takeda's Nesina (alogliptin), respectively. (closeconcerns.com)
  • Stress echo and nuclear stress testing have slightly better accuracy than treadmill exercise stress testing in identifying coronary artery disease, but have never been shown to improve patient oriented outcomes after a negative workup in the ED. (tomwademd.net)
Diagnosis2
  • A number of tests are useful to help with diagnosis, including electrocardiograms (ECGs), blood tests and coronary angiography. (wikipedia.org)
  • Scientists have now come up with a new technology that involves cancer diagnosis through a simple urine test using a strip of paper, making diagnosis simple and affordable for people. (medicaldaily.com)
Ischaemia2
  • The basal septum is supplied by the first septal perforator artery (a very proximal branch of the LAD), so ischaemia/infarction of the basal septum would imply involvement of the proximal LAD or LMCA. (litfl.com)
  • Although cardiovascular death, myocardial infarction or severe recurrent ischaemia were not proven better with ronalazine, the individual component of recurrent ischaemia was significantly reduced by ranolazine - demonstrated as safe. (escardio.org)
Troponin1
Coronary angiography1
Inhibitors2
  • After discussing the design of the study (n=6,103, event-driven, with a glimepiride comparator group and estimated run time of six to seven years), he highlighted the exceptional differences between CAROLINA and other CVOTs for DPP-4 inhibitors, especially SAVOR-TIMI 53 (for BMS/AZ's Onglyza [saxagliptin]) and EXAMINE (for Takeda's Nesina [alogliptin]. (closeconcerns.com)
  • [ 6 ] Ever since, the spectrum of antianginal strategies has been widened by the introduction of newer drugs such as calcium antagonists, inhibitors of the I F -channel, late inward sodium channel current inhibitors, and modulators of myocardial metabolism. (medscape.com)
Stents1
  • Stress tests have a high false positive rate (as high as 80%) leading to unnecessary angiograms, cardiac stents and CABG. (tomwademd.net)
Investigators1
Tissue1
Trials1
  • The new drug alternatives to treat Type 2 diabetes mellitus have been tested in several recent large- scale intervention trials in recent years. (emjreviews.com)
Discharge3
  • If the chest pain was considered to be of possible coronary origin, the patient was then evaluated by the cardiologist on duty according to a chest pain unit protocol consisting of early exercise testing followed by hospitalization and a coronary angiogram or discharge depending on the exercise testing result. (thoracickey.com)
  • Risk assessment with stress testing should be performed unless contraindicated, preferably before discharge from hospital. (bmj.com)
  • If no follow-up is available, consider further testing or observation prior to discharge. (tomwademd.net)
Risk2
  • The mechanisms linking these risk factors with disease manifestation of micro and macrovascular complications are based on gene-environmental interactions, where a less healthy lifestyle, for example smoking, lack of physical exercise, or unhealthy eating habits, result in obesity. (emjreviews.com)
  • There are imaging tests, non-invasive and invasive, that may be used in cardiac risk assessment. (cardiachealth.org)
Symptom1
Systolic2
  • 1) reduction in resting and exercise heart rate and cardiac output, (2) reduction of systolic and diastolic blood pressure at rest and on exercise, (3) inhibition of isoproterenol induced tachycardia, and (4) reduction in reflex orthostatic tachycardia. (nih.gov)
  • In standard animal or human pharmacological tests, beta-adrenoreceptor blocking activity of atenolol tablets have been demonstrated by: (1) reduction in resting and exercise heart rate and cardiac output, (2) reduction of systolic and diastolic blood pressure at rest and on exercise, (3) inhibition of isoproterenol induced tachycardia, and (4) reduction in reflex orthostatic tachycardia. (nih.gov)
Results1
  • Another name for this test is coronary artery calcium scoring: it results in a number reflecting the degree and extent of calcium deposits in the walls of the coronary arteries. (cardiachealth.org)
Annually1
Angina1
  • After the initial 6 weeks of escalating antianginal therapy pre-randomization, 24% (i.e. 48 out of 200) of the population were Canadian Angina Class 1 or 0 consistent with the overall pre-randomization exercise times of approximately 7 METS or completion of standard Bruce Stage 2. (medscape.com)
Tachycardia3
  • A significant beta-blocking effect of atenolol, as measured by reduction of exercise tachycardia, is apparent within one hour following oral administration of a single dose. (nih.gov)
  • Maximum reduction in exercise tachycardia occurs within 5 minutes of an intravenous dose. (nih.gov)
  • The effect on exercise tachycardia of a single 10 mg intravenous dose is largely dissipated by 12 hours, whereas beta-blocking activity of single oral doses of 50 mg and 100 mg is still evident beyond 24 hours following administration. (nih.gov)
Chest pain1
Logistic regression1
  • In multiple logistic regression analyses for independent predictors of myocardial damage, the adjusted odds ratios for myocardial damage (peak CK >3,000 U/L) in quartiles 3 and 4 of the D-T3-time were 4.0 (95% CI: 1.0-16.1) and 7.0 (95% confidence interval (CI): 1.4-36.0), respectively. (go.jp)
Clinical1
  • 9 After preclinical testing and clinical evaluation in relatively simple coronary artery lesions, 10-12 the ABSORB everolimus-eluting bioresorbable vascular scaffold (BVS) received CE-mark approval on 14 December 2010 and is since then increasingly being used in clinical practice across Europe and the rest of the world. (radcliffecardiology.com)
Artery1
Noninvasive1
  • Magnetic resonance imaging (MRI) is a noninvasive medical test that helps physicians diagnose and treat medical conditions. (cardiachealth.org)
Treadmill1
  • Treadmill exercise testing using a modified Bruce protocol was performed pre-randomization and 6 weeks later. (medscape.com)
Proximal1
  • Cath report: proximal LAD 90% ulcerative lesion with timi-3 flow. (blogspot.com)